Drug Trial Radar · NCT00171366
A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
Last checked: Nov 19, 2026Latest source record: Apr 6, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,422
Actual
Start
Jul 2004
Primary completion
Jul 2005
Study completion Jul 2005
Sponsor
- Lead sponsor
- NovartisNovartis (NVS)
- Sponsor type
- Industry
- Collaborators
- Pfizer
- First posted
- Sep 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone.
Conditions
- Hypertension
Interventions
amlodipine/benazeprilDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in mean sitting diastolic blood pressure at week 6
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Novartis Pharmaceuticals
East Hanover, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.